Bridging the gap between #targetdiscovery and autonomous chemistry pipelines is critical to the future of AI drug discovery, and Discovery on Target remains one of the premier events where the #drugdiscovery community tackles these challenges head-on. Don't miss Petrina Kamya, Ph.D. (Global Head of AI Platforms & VP, Insilico Medicine; President, Insilico Medicine Canada) as she presents: 📍 "Building Agentic AI Workflows for Drug Discovery: From LLM Tools to Autonomous Discovery Pipelines" Join us in Boston (Sept 28 - Oct 1) at the Sheraton Boston to see how autonomous agentic workflows inside Pharma.AI are streamlining target identification (PandaOmics) and de novo molecular generation (Chemistry42). 👉 Details & Session Info: lnkd.in/p/gE8WYw6N